Drugstore chain Rite Aid Corporation (NYSE: RAD) announced fourth-quarter 2023 results, reporting a modest increase in revenues and a narrower net loss.
Fourth-quarter loss, excluding special items, improved to $1.24 per share from a loss of $2.24 per share in the same period of last year. On a reported basis, the net loss attributable to common stockholders was $241.3 million or $4.39 per share, compared to a loss of $389.1 million or $7.18 per share in the prior-year quarter.
Total revenues increased modestly to $6.09 billion in the fourth quarter from $6.07 billion in the corresponding period of 2022. Retail comparable same-store prescriptions moved up 5.2% while comparable same-store prescriptions, excluding COVID impacts, increased 9.7%.
“We are making progress in our turnaround program to drive performance acceleration that we expect will help mitigate fiscal 2024 challenges related to reimbursement, COVID headwinds, and enrollment at Elixir, and to drive meaningful Adjusted EBITDA growth in fiscal 2025 and 2026,” said interim chief executive officer Elizabeth Burr.
Most Popular
McCormick & Company (MKC) Q2 2024 Earnings: Key financials and quarterly highlights
McCormick & Company, Incorporated (NYSE: MKC) reported second quarter 2024 earnings results today. Net sales decreased 1% year-over-year to $1.64 billion. Sales declined 1% in constant currency as well. Net income
Micron (MU) Q3 2024 profit exceeds expectations; revenue up 82%
Micron Technology Inc. (NASDAQ: MU) reported a sharp increase in revenues for the third quarter of 2024, and the chipmaker turned to a profit from a loss last year. The
Important takeaways from FedEx Corporation’s (FDX) Q4 2024 earnings report
FedEx Corporation (NYSE: FDX) this week reported better-than-expected fourth-quarter numbers and raised its FY25 earnings guidance, triggering a stock rally that drove up FDX to a three-year high. Reflecting the
